Search results
Results From The WOW.Com Content Network
Before you buy stock in Roche Ag, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Roche Ag wasn ...
Roche's lawsuit, filed in July, said the biosimilar would infringe several patents related to the manufacture and use of its biologic drug. Biogen and Bio-Thera did not respond to the allegations ...
FRANKFURT (Reuters) -Shares in Roche dropped to a two-month low on Thursday after an experimental weight-loss pill that carries high market hopes was linked to an elevated rate of temporary side ...
Roche might give Lilly and Novo Nordisk a run for their money -- sometime down the road.
Judge Louis Stanton dismissed the privacy concerns as "speculative", and ordered YouTube to hand over documents totaling about 12 terabytes of data. [12] On the other hand, Stanton rejected Viacom's request that YouTube hand over the source code of its search engine, saying that it was a trade secret.
Roche on Friday announced another extension of its $4.3 billion offer for gene therapy specialist Spark Therapeutics, this time until June 3, saying a review by U.S. authorities is taking longer ...
For premium support please call: 800-290-4726 more ways to reach us
Now that Spark Therapeutics (NASDAQ: ONCE) agreed on a definitive merger with Roche (OTCMKTS:RHHBY) for $114.50 a share, only one question remains for investors. Should investors keep holding ...